The data show clear changes in food spending following adoption, said study author Sylvia Hristakeva, an assistant professor at Cornells SC Johnson College of Business, in a statement from the university
The trial also demonstrated superiority to placebo for all confirmatory secondary outcomes assessed, including pain-free walking distance at week 52, health-related quality of life (Vascular Quality of Life Questionnaire-6) at week 52, and maximum walking distance at week 57
SAN ANTONIO Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes as are the investigational 50-mg oral dose and the injectable 2.4-mg dose (Wegovy), in new research
Ideal candidates are adults with a body mass index (BMI) of 30 or higher, or 27 with weight-related health issues
Clinical evidence also suggests potential advantages in wound healing
While possible in some settings, it is not clinically advisable